UNIGE document Scientific Article - Review
previous document  unige:44530  next document
add to browser collection

Epigénétique et cancer

Published in Revue médicale suisse. 2007, vol. 3, no. 100, p. 540-2,544-5
Abstract Since the early 80's, cancer research has been dominated by scientific breakthroughs demonstrating the genetic origin of cancer. Thousands of genetic alterations have been identified, affecting more than one hundred cell regulating genes. In the past ten years, our understanding of carcinogenesis has evolved: cancer is both a genetic and an epigenetic disease. Epigenetic modifications play a fundamental biological role in the initiation and progression of cancer by altering the expression of cell cycle regulation genes. Unlike genetic mutations, epigenetic modifications are potentially reversible. Thus, epigenetic inhibitors are currently evaluated as anticancer drugs. Moreover, DNA methylation study holds promise as biological marker for classification, diagnostic and prognostic purposes in clinical practice.
Keywords DNA MethylationEpigenesis, GeneticHumansNeoplasms/drug therapy/genetics
PMID: 17410941
Full text
Article (Published version) (49 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Article (Published version) (3.1 MB) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://www.revmed.ch/rms/2007/RMS-100/32080
Research group Pathogénèse du syndrome néphrotique idiopathique de l'enfant (180)
(ISO format)
KERN, Ilse, ROSSIER, Michel, CHAPPUIS, Pierre. Epigénétique et cancer. In: Revue médicale suisse, 2007, vol. 3, n° 100, p. 540-2,544-5. https://archive-ouverte.unige.ch/unige:44530

429 hits



Deposited on : 2015-01-06

Export document
Format :
Citation style :